一项中度至极重度慢性阻塞性肺疾病(COPD)中国受试者接受 Revefenacin 雾化吸入用溶液治疗的随机、双盲、安慰剂对照、平行研究
[Translation] A randomized, double-blind, placebo-controlled, parallel study of Revefenacin solution for inhalation in Chinese subjects with moderate to very severe chronic obstructive pulmonary disease (COPD)
在中国中度至极重度 COPD 受试者人群中,证实与安慰剂相比,revefenacin 吸入用溶液 175 mcg 每日一次雾化治疗 12 周的有效性
[Translation] To demonstrate the efficacy of once-daily nebulized revefenacin solution for inhalation 175 mcg compared with placebo for 12 weeks in a Chinese population of subjects with moderate to very severe COPD
Mylan生产的revefenacin吸入用溶液(175 mcg/3 mL)在健康中国成人男性和女性志愿者中的单剂量空腹给药生物利用度研究
[Translation] A single-dose fasting bioavailability study of Mylan's revefenacin inhalation solution (175 mcg/3 mL) in healthy Chinese adult male and female volunteers
本研究的主要目的是评估Mylan的Revefenacin吸入用溶液(175 mcg/3 mL)在空腹条件下单剂量雾化吸入给药175 mcg剂量(1×175 mcg/3 mL)后的生物利用度。
次要目的是评价revefenacin吸入用溶液(175 mcg/3 mL)单剂量吸入给药后的安全性和耐受性。
[Translation] The primary objective of this study was to evaluate the bioavailability of Mylan's Revefenacin Inhalation Solution (175 mcg/3 mL) after a single nebulized inhalation dose of 175 mcg (1×175 mcg/3 mL) under fasting conditions.
The secondary objective was to evaluate the safety and tolerability of a single inhaled dose of Revefenacin Inhalation Solution (175 mcg/3 mL).
/ CompletedNot Applicable Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis
The primary objective of the present multicentre, prospective, non-interventional study (NIS) is gathering knowledge on the actual use and effectiveness of Elidel® in Chinese patients with mild to moderate AD affecting sensitive skin areas in routine clinical practice.
100 Clinical Results associated with Medicine Meda Pharmaceutical Information Consultancy (Beijing)
0 Patents (Medical) associated with Medicine Meda Pharmaceutical Information Consultancy (Beijing)
100 Deals associated with Medicine Meda Pharmaceutical Information Consultancy (Beijing)
100 Translational Medicine associated with Medicine Meda Pharmaceutical Information Consultancy (Beijing)